Molecular and genetic insights into an infantile epileptic encephalopathy – CDKL5 disorder
- 23 January 2017
- journal article
- review article
- Published by Springer Nature in Frontiers in Biology
- Vol. 12 (1) , 1-6
Abstract
The discovery that mutations in cyclin-dependent kinase-like 5 (CDKL5) gene are associated with infantile epileptic encephalopathy has stimulated world-wide research effort to understand the molecular and genetic basis of CDKL5 disorder. Given the large number of literature published thus far, this review aims to summarize current genetic studies, draw a consensus on proposed molecular functions, and point to gaps of knowledge in CDKL5 research.Keywords
This publication has 32 references indexed in Scilit:
- Functional abilities in children and adults with the CDKL5 disorderAmerican Journal of Medical Genetics Part A, 2016
- Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1Biological Psychiatry, 2016
- Mapping Pathological Phenotypes in a Mouse Model of CDKL5 DisorderPLOS ONE, 2014
- Mutations in the C-terminus of CDKL5: proceed with cautionEuropean Journal of Human Genetics, 2013
- Recurrent mutations in the CDKL5 gene: Genotype–phenotype relationshipsAmerican Journal of Medical Genetics Part A, 2012
- mTOR: A pathogenic signaling pathway in developmental brain malformationsTrends in Molecular Medicine, 2011
- CDKL5, a Protein Associated with Rett Syndrome, Regulates Neuronal Morphogenesis via Rac1 SignalingThe Journal of Neuroscience, 2010
- Key clinical features to identify girls with CDKL5 mutationsBrain, 2008
- The Story of Rett Syndrome: From Clinic to NeurobiologyNeuron, 2007
- CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patientsJournal of Medical Genetics, 2006